Illidge T - Search Results

1

Microscopic intratumoral dosimetry of radiolabeled antibodies is a critical determinant of successful radioimmunotherapy in B-cell lymphoma.

Du Y, Honeychurch J, Glennie M, Johnson P, Illidge T. Du Y, et al. Among authors: illidge t. Cancer Res. 2007 Feb 1;67(3):1335-43. doi: 10.1158/0008-5472.CAN-06-2495. Cancer Res. 2007. PMID: 17283171

2

Antibody-induced intracellular signaling works in combination with radiation to eradicate lymphoma in radioimmunotherapy.

Du Y, Honeychurch J, Cragg MS, Bayne M, Glennie MJ, Johnson PW, Illidge TM. Du Y, et al. Blood. 2004 Feb 15;103(4):1485-94. doi: 10.1182/blood-2003-06-2037. Epub 2003 Oct 23. Blood. 2004. PMID: 14576070 Free article.

3

Phase 1/2 study of fractionated (131)I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy.

Illidge TM, Bayne M, Brown NS, Chilton S, Cragg MS, Glennie MJ, Du Y, Lewington V, Smart J, Thom J, Zivanovic M, Johnson PW. Illidge TM, et al. Blood. 2009 Feb 12;113(7):1412-21. doi: 10.1182/blood-2008-08-175653. Epub 2008 Dec 12. Blood. 2009. PMID: 19074729 Free article. Clinical Trial.

4

Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade.

Dovedi SJ, Adlard AL, Lipowska-Bhalla G, McKenna C, Jones S, Cheadle EJ, Stratford IJ, Poon E, Morrow M, Stewart R, Jones H, Wilkinson RW, Honeychurch J, Illidge TM. Dovedi SJ, et al. Cancer Res. 2014 Oct 1;74(19):5458-68. doi: 10.1158/0008-5472.CAN-14-1258. Cancer Res. 2014. PMID: 25274032

5

Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell-dependent immunity to B-cell lymphoma.

Honeychurch J, Glennie MJ, Johnson PW, Illidge TM. Honeychurch J, et al. Blood. 2003 Aug 15;102(4):1449-57. doi: 10.1182/blood-2002-12-3717. Epub 2003 Apr 24. Blood. 2003. PMID: 12714523 Free article.

6

Cyclophosphamide inhibition of anti-CD40 monoclonal antibody-based therapy of B cell lymphoma is dependent on CD11b+ cells.

Honeychurch J, Glennie MJ, Illidge TM. Honeychurch J, et al. Cancer Res. 2005 Aug 15;65(16):7493-501. doi: 10.1158/0008-5472.CAN-04-3808. Cancer Res. 2005. PMID: 16103104

7

Antitumor Efficacy of Radiation plus Immunotherapy Depends upon Dendritic Cell Activation of Effector CD8+ T Cells.

Dovedi SJ, Lipowska-Bhalla G, Beers SA, Cheadle EJ, Mu L, Glennie MJ, Illidge TM, Honeychurch J. Dovedi SJ, et al. Cancer Immunol Res. 2016 Jul;4(7):621-630. doi: 10.1158/2326-6066.CIR-15-0253. Epub 2016 May 30. Cancer Immunol Res. 2016. PMID: 27241845 Free PMC article.

8

Radioimmunotherapy in the pi-BCL1 B cell lymphoma model: efficacy depends on more than targeted irradiation alone.

Illidge T, Honeychurch J, Vandersteen A, Cragg M. Illidge T, et al. Cancer Biother Radiopharm. 2000 Dec;15(6):581-91. doi: 10.1089/cbr.2000.15.581. Cancer Biother Radiopharm. 2000. PMID: 11190490

9

The importance of antibody-specificity in determining successful radioimmunotherapy of B-cell lymphoma.

Illidge TM, Cragg MS, McBride HM, French RR, Glennie MJ. Illidge TM, et al. Blood. 1999 Jul 1;94(1):233-43. Blood. 1999. PMID: 10381518 Free article.

10

Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells.

Ivanov A, Beers SA, Walshe CA, Honeychurch J, Alduaij W, Cox KL, Potter KN, Murray S, Chan CH, Klymenko T, Erenpreisa J, Glennie MJ, Illidge TM, Cragg MS. Ivanov A, et al. Among authors: illidge tm. J Clin Invest. 2009 Aug;119(8):2143-59. doi: 10.1172/JCI37884. Epub 2009 Jul 20. J Clin Invest. 2009. PMID: 19620786 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

190 results

Search Page

Filters